NCT04483804 Application of Radiomics in Breast Cancer
| NCT ID | NCT04483804 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2023-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2018-01-01 with a primary completion date of 2023-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of breast cancer Exclusion Criteria: Missing pathology Missing follow-up results Missing data
Contact & Investigator
pintong Huang
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Frequently Asked Questions
Who can join the NCT04483804 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04483804 currently recruiting?
Yes, NCT04483804 is actively recruiting participants. Contact the research team at zimei.lin@zju.edu.cn for enrollment information.
Where is the NCT04483804 trial being conducted?
This trial is being conducted at Hanzhou, China.
Who is sponsoring the NCT04483804 clinical trial?
NCT04483804 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is pintong Huang at Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.